Philips Collaborates With Leading Institutes to Bring Its Breakthrough Spectral CT Imaging into the Interventional Suite

November 28, 2021 —Royal Philips, a leader in health technology, unveiled its vision for interventional medicine by bringing its breakthrough spectral CT imaging technology into a hybrid Angio CT suite. By combining the company’sSpectral CT 7500 systemand itsimage-guided therapy system – Azurion with FlexArm在单一的介入套件解决方案中，飞利浦的目标是为介入医生提供即时的桌面访问这两种关键的成像方式，这样他们就可以在一个房间内完成需要CT和血管造影指导的操作。为了开发这一综合解决方案，飞利浦正与领先的临床机构密切合作，如梅奥诊所和浸信会健康的迈阿密心脏和血管研究所。该研究将于11月28日至12月2日在芝加哥举行的2021年北美放射学会年会上发表。

光谱CT 7500首次与Azurion平台相结合，其目标是提供一个无缝的工作流程环境，其中所有必要的成像方式都可以直接在患者的桌子上获得，从桌子边的工作地点完全可控。当不使用时，每一种模式都能平稳地从病人桌子滑到停车位置，让介入团队不受限制地接触病人。如果需要，每个系统都可以独立工作。对于介入医生来说，它可以实现无缝高效的工作流程，而不需要将患者从一个成像套件转移到另一个。对于病人来说，这意味着他们的医生可以在一次手术中充分利用两种系统的优势。

Requiring just one scan to capture all the spectral information required to differentiate and quantify different tissues, Philips’ always-on spectral CT technology enables improved detection, delineation, and quantification of lesions, leading to better-informed planning for minimally-invasive procedures and more precise interventions. In oncology, spectral CT has also demonstrated a higher sensitivity in detecting malignant findings and has improved readings of incidental findings.^{1, 2}

“There has been a tremendous evolution in the image-guided therapy environment,” said Dr. Barry T. Katzen, founder and chief medical executive of Baptist’s Health’s Miami Cardiac & Vascular Institute. “We are really excited about the merger and integration of these technologies in that it might allow us to look at the treatment of a number of diseases in very new and innovative ways, potentially offering new treatment opportunities and improving patient care. I am looking forward to investigating the possibilities of this promising innovation.”

“With this innovation, we are taking a uniquely patient-centric approach, aimed at bringing the latest interventional imaging modalities to the patient table rather than moving the patient to the individual modalities,” said Karim Boussebaa, general manager of image guided therapy systems at Philips. “We are excited to be co-creating the future of image guided therapy with leading clinical partners by combining the best of our award-winning modalities into a single suite.”

JoinPhilips at RSNA 2021where the company will spotlight its latest advanced technology driving connected workflows and smart connected imaging systems.

For more information:www.usa.philips.com

References:

¹Analysis by Aarhus University Hospital Aarhus, Denmark. Results from case studies are not predictive of results in other cases. Results in other cases may vary.
²Analysis by University Hospital Cleveland, USA. Results from case studies are not predictive of results in other cases. Results in other cases may vary.